wdt_ID wdt_created_by wdt_created_at wdt_last_edited_by wdt_last_edited_at Cancer Type Drug Brand Name Drug Generic Name Company Patient Assistance Program
1 lfsweb_admin 02/20/2026 09:59 AM lfsweb_admin 02/20/2026 09:59 AM Melanoma Keytruda pembrolizumab Merck
2 lfsweb_admin 02/20/2026 09:59 AM lfsweb_admin 02/20/2026 09:59 AM Non-Small Cell Lung Keytruda pembrolizumab Merck
3 lfsweb_admin 02/20/2026 09:59 AM lfsweb_admin 02/20/2026 09:59 AM Renal Cell Carcinoma Keytruda pembrolizumab Merck
4 lfsweb_admin 02/20/2026 09:59 AM lfsweb_admin 02/20/2026 09:59 AM Breast Cancer Keytruda pembrolizumab Merck
5 lfsweb_admin 02/20/2026 09:59 AM lfsweb_admin 02/20/2026 09:59 AM Mesothelioma Keytruda pembrolizumab Merck
6 lfsweb_admin 02/20/2026 09:59 AM lfsweb_admin 02/20/2026 09:59 AM Hodgkin Lymphoma Keytruda pembrolizumab Merck
7 lfsweb_admin 02/20/2026 09:59 AM lfsweb_admin 02/20/2026 09:59 AM Head & Neck Keytruda pembrolizumab Merck
8 lfsweb_admin 02/20/2026 09:59 AM lfsweb_admin 02/20/2026 09:59 AM Urothelial Keytruda pembrolizumab Merck
9 lfsweb_admin 02/20/2026 09:59 AM lfsweb_admin 02/20/2026 09:59 AM Colorectal Keytruda pembrolizumab Merck
10 lfsweb_admin 02/20/2026 09:59 AM lfsweb_admin 02/20/2026 09:59 AM Hepatocellular Keytruda pembrolizumab Merck
11 lfsweb_admin 02/20/2026 09:59 AM lfsweb_admin 02/20/2026 09:59 AM Esophageal Keytruda pembrolizumab Merck
12 lfsweb_admin 02/20/2026 09:59 AM lfsweb_admin 02/20/2026 09:59 AM Melanoma Opdivo nivolumab Bristol Myers Squibb
13 lfsweb_admin 02/20/2026 09:59 AM lfsweb_admin 02/20/2026 09:59 AM Non-Small Cell Lung Opdivo nivolumab Bristol Myers Squibb
14 lfsweb_admin 02/20/2026 09:59 AM lfsweb_admin 02/20/2026 09:59 AM Renal Cell Carcinoma Opdivo nivolumab Bristol Myers Squibb
15 lfsweb_admin 02/20/2026 09:59 AM lfsweb_admin 02/20/2026 09:59 AM Breast Cancer Opdivo nivolumab Bristol Myers Squibb
16 lfsweb_admin 02/20/2026 09:59 AM lfsweb_admin 02/20/2026 09:59 AM Mesothelioma Opdivo nivolumab Bristol Myers Squibb
17 lfsweb_admin 02/20/2026 09:59 AM lfsweb_admin 02/20/2026 09:59 AM Hodgkin Lymphoma Opdivo nivolumab Bristol Myers Squibb
18 lfsweb_admin 02/20/2026 09:59 AM lfsweb_admin 02/20/2026 09:59 AM Head & Neck Opdivo nivolumab Bristol Myers Squibb
19 lfsweb_admin 02/20/2026 09:59 AM lfsweb_admin 02/20/2026 09:59 AM Urothelial Opdivo nivolumab Bristol Myers Squibb
20 lfsweb_admin 02/20/2026 09:59 AM lfsweb_admin 02/20/2026 09:59 AM Colorectal Opdivo nivolumab Bristol Myers Squibb
21 lfsweb_admin 02/20/2026 09:59 AM lfsweb_admin 02/20/2026 09:59 AM Hepatocellular Opdivo nivolumab Bristol Myers Squibb
22 lfsweb_admin 02/20/2026 09:59 AM lfsweb_admin 02/20/2026 09:59 AM Esophageal Opdivo nivolumab Bristol Myers Squibb
23 lfsweb_admin 02/20/2026 09:59 AM lfsweb_admin 02/20/2026 09:59 AM Breast Cancer Perjeta pertuzumab Genentech
Cancer Type Drug Brand Name Drug Generic Name Company Patient Assistance Program